Dalteparin and Sertraline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordDalteparin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking sertraline (an antidepressant) along with dalteparin (Fragmin), a blood thinner given by injection. Each one affects bleeding in its own way. Sertraline makes the tiny cells that help your blood clot (platelets) work a little less well, and dalteparin is designed to slow clotting. Put together, they can add up and raise your chance of bleeding or bruising.
Watch for things like nosebleeds, easy bruising, small red dots on the skin, or any bleeding that won't stop. This is very manageable. Keep taking both as prescribed, and let your pharmacist or doctor know about any unusual bleeding so your care team can keep an eye on you.
Effect: Additive bleeding risk with concurrent sertraline and dalteparin.
Mechanism: SSRIs deplete platelet serotonin, impairing platelet aggregation and primary hemostasis; this is additive to the anticoagulant effect of dalteparin (LMWH, anti-Xa). This is a pharmacodynamic interaction, not a CYP-mediated PK change. Neither agent requires the other's presence for activation.
- Severity: Major; onset: delayed; evidence: probable (case-control/cohort data).
- Manifestations: epistaxis, ecchymosis, hematoma, petechiae, and rarely life-threatening hemorrhage.
- Management: Monitor for bleeding signs, counsel the patient, and individualize therapy. Consider CBC/signs of blood loss if clinically indicated.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients about the elevated bleeding risk.1. Platelet serotonin release plays a key role in preserving hemostasis. Studies using case-control and cohort designs have demonstrated that using SSRIs (for example, sertraline) alongside anticoagulants has been linked to a greater bleeding risk 231. The joint use of sertraline and an anticoagulant may increase the likelihood of bleeding. Reported bleeding events have encompassed epistaxis, ecchymosis, hematoma, petechiae, and life-threatening hemorrhages 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Your care team can manage this combination safely with awareness and monitoring.
- Keep taking both exactly as prescribed unless your doctor tells you otherwise.
- Your team may watch you more closely for bleeding, especially early on and when doses change.
- Report any nosebleeds, unusual bruising, tiny red skin spots, pink or dark urine, black stools, or bleeding that won't stop.
- Mention this combination to any new provider, and ask your pharmacist before adding aspirin, NSAIDs, or other blood thinners.
If you notice heavy or uncontrolled bleeding, seek medical care right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported an increased risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched with randomly chosen patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleeds over 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for first bleeds during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. The SSRIs involved in patients who bled during concomitant use were sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization for non-gastrointestinal bleeding. Using national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients on SSRIs had a higher risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the effect of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants received warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and periodically afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been linked to a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events related to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Dalteparin and Sertraline together?
Taking sertraline with dalteparin can add up to a higher bleeding risk, so keep taking both as prescribed and promptly report any unusual bleeding or bruising to your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Dalteparin and Sertraline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Dalteparin and Sertraline interaction managed?
Your care team can manage this combination safely with awareness and monitoring. Keep taking both exactly as prescribed unless your doctor tells you otherwise. Your team may watch you more closely for bleeding, especially early on and when doses change. Report any nosebleeds, unusual bruising, tiny red skin spots, pink or dark urine, black stools, or bleeding that won't stop. Mention this combinat… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Dalteparin or Sertraline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Dalteparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist